Navigation Links
Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
Date:9/2/2008

LAUSANNE, Switzerland, September 2 /PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions and particularly oncology, today announced the signature of a research project with the Ecole Polytechnique Federale de Lausanne (EPFL), aimed at the identification of novel small molecules and peptides that interfere with pathways controlling cell fate specification. The project, named Debio 0826, could lead to the development of potential therapeutic compounds and to the identification of new targets to fight cancer stem cells.

Following the signature of an EPFL-Debiopharm partnership on February 12, this first joint research project will be performed under the supervision of Dr. Freddy Radtke, Associate Professor at the Swiss Institute for Experimental Cancer Research (ISREC) and Dr. Gerardo Turcatti, MER, Director of the Biomolecular Screening Facility (BSF), two groups at the EPFL. Debio 0826 will benefit from the multiple molecular and genetic tools generated by Dr. Radtke's group over the past 10 years, as well as the expertise of Dr. Turcatti in the molecular screening field.

"Targeting pathways controlling cell fate specification could generate innovative anti-cancer drugs with anti-tumoural, anti-metastatic and anti-angiogenic properties to treat tumours that are currently resistant to standard therapies," said Kamel Besseghir, CEO of Debiopharm S.A.

About Debiopharm Group

Debiopharm Group is a global biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. Debiopharm develops its products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing. Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and
'/>"/>

SOURCE Debiopharm Group
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 2013  Aribex, Inc., manufacturer of the newly released ... new color option, black with gray trim, of the ... markets. The popular white with light blue trim Pro ... be available and both models can be purchased from ... http://photos.prnewswire.com/prnh/20130522/CL19573 ) "Dental offices are adding ...
(Date:5/22/2013)... May 22, 2013 Attorney Advertising -- Bronstein, ... on behalf of purchasers of the securities of ... AMAG -News).  The investigation focuses on whether the ... On May 22, 2013, Shares of ... after the company announced in regulatory filing that ...
(Date:5/22/2013)... and CAESAREA, Israel , May ... , New clinical data presented from the DEFLECT-I study ... Device reduces brain lesion volume during TAVR (Transcatheter Aortic ... Keystone Heart Scientific Advisory Board announces consensus on ... rising regarding the importance and need for cerebral protection ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AMAG Pharmaceuticals, Inc. 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 2New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 3New Clinical Data Presented at EuroPCR Demonstrates that TriGuard Reduces Brain Lesion Volume during TAVR 4
... study published today in the,journal Current Medical ... superior to Cymbalta®,(duloxetine) in the acute treatment ... was at least as efficacious in,long-term treatment. ... reuptake inhibitor - ASRI) to duloxetine (a,serotonin ...
... - Both co-primary endpoints, Wake After Sleep Onset and ... Sleep, were met at both doses - Evotec to ... 10am EST) today , HAMBURG, Germany | OXFORD, England, ... today positive top-line,results from its first phase II clinical ...
Cached Medicine Technology:Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 2Cipralex demonstrates superiority to duloxetine for acute treatment,of depression in new study 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4
(Date:5/23/2013)... New techniques in imaging of brain activity developed ... Neurological Institute, and his colleagues lead to improved ... combination of electroencephalogram (EEG) and functional magnetic resonance ... the areas generating epileptic seizures, giving neurosurgeons a ... if appropriate. These results were presented at ...
(Date:5/23/2013)... , , WEDNESDAY, May 22 (HealthDay News) -- The success of ... born with a serious airway malformation sheds light on new ... A report in the May 23 New England Journal ... At first, the baby born five weeks early seemed ... eating when he was 6 weeks old. Just two weeks ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 According to ... [Converged Services; Policy Management; Subscriber Data Management (SDM); Telecom ... Forecasts and Analysis (2013 – 2018)", published by MarketsandMarkets, ... by 2018 at a CAGR of 9.15% from 2013 ... Market Data Tables , 84 Figures , ...
(Date:5/23/2013)... Located at 22343 La Palma Ave. #125, fitness ... Grand Opening Family Fun Charity event on May 11, 2013 ... physical fitness. Sponsored by many different vendors like Chick-fil-a and ... Grand Opening featured mini boot camp sessions and raffled off ... Yorba Linda fitness center has to offer. ...
(Date:5/23/2013)... In Florida, residents have not been hit ... however, that Florida’s good luck will continue, warns Rick Knabb, ... he encourages residents, it is important to prepare as if ... predicting there to be a 50-percent chance that a major ... season lasting from June 1 to November 30 in Florida, ...
Breaking Medicine News(10 mins):Health News:New imaging techniques used to help patients suffering from epilepsy 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 2Health News:Service Delivery Platform (SDP) Market Is Growing at a CAGR of 9.15% & to Reach $6.94 Billion by 2018 - New Report by MarketsandMarkets 3Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 2Health News:Yorba Linda Personal Trainer Celebrates Fit Body Boot Camp Yorba Linda Grand Opening by Hosting a Family Fun Charity Event 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2
... America,s Future co-director Roger Hickey , Economic Policy ... Economic and Policy Research co-director Dean Baker ... President Obama ,s summit today on the nation,s future ... LAWRENCE MISHEL We applaud President ...
... Feb. 23 The non-profit LENA(TM) Foundation, which develops ... language disorders, has released two case studies showing how ... autism treatment. The LENA software enables the clinician ... turns at 5-minute and hourly intervals over the course ...
... eFoodSafety.com, Inc., (OTC Bulletin Board: EFSF) an emerging ... dermatology, environmental and nutraceutical products, today announced that Martin ... future Chairman and CEO of eFoodSafety.com, has purchased stock ... total of 100,000 shares in the open market on ...
... in Phoenix to Focus on Catheter Reduction and ... SEGUNDO, Calif., Feb 23 DaVita Inc., a ... 2009 Clinical Priorities to its partnering nephrologists during ... of the largest gatherings of nephrologists of the ...
... Practices provide guidance for healthcare systems in ... and community engagementWASHINGTON, Feb. 23 The ... to improving healthcare quality, has endorsed 45 ... care that is culturally appropriate and patient-centered. ...
... 23 Vanda Pharmaceuticals Inc. (Nasdaq: ... statement regarding two letters sent to Vanda by Tang Capital ... its intent to, among other things, nominate two directors to ... and submit proposals at the 2009 Annual Meeting to amend ...
Cached Medicine News:Health News:Progressive Leaders at White House Summit Today Underscore Need for Health Care Reform 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 2Health News:LENA Foundation Technology Measures Effectiveness of Autism Therapy 3Health News:eFoodSafety.com Announces Open Market Stock Purchase by Management 2Health News:DaVita Releases Top Clinical Priorities for 2009 2Health News:DaVita Releases Top Clinical Priorities for 2009 3Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 2Health News:National Quality Forum Endorses Guidelines to Reduce Disparities in Healthcare and Make Care Patient-Centered and Culturally Appropriate 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 2Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 3Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 4Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 5Health News:Vanda Pharmaceuticals Responds to Announcement and Filing by a Group Led by Tang Capital Partners, LP 6
... The Stereo Cube is used to diagnose ... without the use of polarized glasses. The ... of binocularity, stereopsis, visual attention, form and depth ... of 850 to 450 seconds of arc and ...
... created to simplify stereopsis screening in children. It ... cylindrical gratings. Lang Stereotest II measures disparities: Moon ... 600 seconds of arc plus monocularly visible star. ... dots are smaller and less dense. This disparity ...
... provide accurate measurement of stereopsis. These ... polarized glasses. The original comes with ... a thin plastic frame with plastic ... new P/N 4465 Polycarbonate polarized hard ...
... stereo test was developed to test for both ... employs the more reliable red/green glasses to ... not dependent on polarizing spectacles which can be ... an attractive image of a butterfly which makes ...
Medicine Products: